Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 35 Advanced Solid Tumors 20 Carcinoma, Non-Small-Cell Lung 14 Myelodysplastic Syndromes 13 Breast Neoplasms 13 Advanced Solid Tumor 13 Recurrence 10 Ovarian Neoplasms 8 Neoplasms 8 Multiple Myeloma 8 Leukemia, Myelomonocytic, Chronic 8 Triple Negative Breast Neoplasms 7 Solid Tumor 6 Myeloproliferative Disorders 6 Small Cell Lung Carcinoma 5 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Lung Neoplasms 5 Carcinoma, Hepatocellular 5 Advanced Solid Tumour 5 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell 4 Fallopian Tube Neoplasms 4 Colorectal Neoplasms 4 Advanced Malignant Solid Tumor 4 Advanced Lung Cancer 4 Squamous Cell Carcinoma of Head and Neck 3

Interventions

Ciprofloxacin 3 Ceftazidime 3 Vancomycin 2 Cefepime 2 Amikacin 2 pegylated granulocyte colony-stimulating factor 1 Teicoplanin 1 Tazobactam 1 Piperacillin 1 Ofloxacin 1 Metronidazole 1 Meropenem 1 Levofloxacin 1 Injections 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Febrile Neutropenia × Injections × 1 year × Clear all

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡